These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 36591255)

  • 1. Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma.
    Liang Z; Sun R; Tu P; Liang Y; Liang L; Liu F; Bian Y; Yin G; Zhao F; Jiang M; Gu J; Tang D
    Front Immunol; 2022; 13():944286. PubMed ID: 36591255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer.
    Li C; Wirth U; Schardey J; Ehrlich-Treuenstätt VV; Bazhin AV; Werner J; Kühn F
    Front Immunol; 2023; 14():1156488. PubMed ID: 37483596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immune-related biomarker index for predicting the effectiveness of immunotherapy and prognosis in hepatocellular carcinoma.
    Wu X; Jin B; Liu X; Mao Y; Wan X; Du S
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10319-10333. PubMed ID: 37273105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma.
    Chen Y; Li ZY; Zhou GQ; Sun Y
    Clin Cancer Res; 2021 Jan; 27(1):330-341. PubMed ID: 33097495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy.
    Wang Z; Song J; Azami NLB; Sun M
    Front Immunol; 2022; 13():802665. PubMed ID: 35572595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatments.
    Wang C; Lu T; Xu R; Chang X; Luo S; Peng B; Wang J; Yao L; Wang K; Shen Z; Zhao J; Zhang L
    J Thorac Dis; 2022 Jun; 14(6):2131-2146. PubMed ID: 35813746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of an immune-related genes prognostic index (IRGPI) model in colon cancer.
    Jin Y; Deng J; Luo B; Zhong Y; Yu S
    Front Endocrinol (Lausanne); 2022; 13():963382. PubMed ID: 36440228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of immune-related hub genes and construction of an immune-related gene prognostic index for low-grade glioma.
    Zhou J; Guo H; Liu L; Jin Z; Zhang W; Tang T
    J Cell Mol Med; 2023 Dec; 27(23):3851-3863. PubMed ID: 37775993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma.
    Dai Y; Qiang W; Lin K; Gui Y; Lan X; Wang D
    Cancer Immunol Immunother; 2021 Apr; 70(4):967-979. PubMed ID: 33089373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Immune-Related Gene Pair Index Predicts Clinical Response and Survival Outcome of Immune Checkpoint Inhibitors in Melanoma.
    Yan J; Wu X; Yu J; Kong Y; Cang S
    Front Immunol; 2022; 13():839901. PubMed ID: 35280982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and verification of an immune-related gene prognostic index for gastric cancer.
    Zhang C; Liu T; Wang J; Zhang J
    Sci Rep; 2022 Sep; 12(1):15693. PubMed ID: 36127384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of an immune-related gene prognostic index for lung adenocarcinoma.
    Liu Z; Lei Y; Shen J; Zhao G; Wang X; Wang Y; Kudo Y; Liao J; Huang Y; Yu T
    J Thorac Dis; 2023 Nov; 15(11):6205-6227. PubMed ID: 38090291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A composite score based on immune-related gene prognostic index and m
    Yang Y; Cai Z; Huang K; Li M; Wang X; Lin Y; Chen S; Yang Z; Lin Z
    Front Genet; 2023; 14():1061569. PubMed ID: 36845378
    [No Abstract]   [Full Text] [Related]  

  • 14. Decoding the immune landscape: a comprehensive analysis of immune-associated biomarkers in cervical carcinoma and their implications for immunotherapy strategies.
    Wang L; Liu H; Feng Y; Liu X; Wang Y; Liu Y; Li H; Zhang Y
    Front Genet; 2024; 15():1340569. PubMed ID: 38933923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation- and fibrinolysis-related genes for predicting survival and immunotherapy efficacy in colorectal cancer.
    Ma Y; Wang B; He P; Qi W; Xiang L; Maswikiti EP; Chen H
    Front Immunol; 2022; 13():1023908. PubMed ID: 36532065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Immune-Related Genes for Establishment of Prognostic Index in Hepatocellular Carcinoma.
    Li Y; Zou L; Liu X; Luo J; Liu H
    Front Cell Dev Biol; 2021; 9():760079. PubMed ID: 34796177
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
    Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
    Front Immunol; 2022; 13():951455. PubMed ID: 36189298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Novel Immune-Related Gene Prognostic Index for Breast Cancer.
    Yao Y; Kong X; Liu R; Xu F; Liu G; Sun C
    Front Immunol; 2022; 13():845093. PubMed ID: 35558081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
    Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
    Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients.
    Xiao Z; Nie K; Han T; Cheng L; Zhang Z; Peng W; Shi D
    J Immunol Res; 2021; 2021():6439975. PubMed ID: 34541005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.